The effect of topical tranexamic acid on the episiotomy bleeding, a clinical trial
Not Applicable
- Conditions
- Episiotomy bleeding rate.Postpartum hemorrhage
- Registration Number
- IRCT20180409039247N4
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 162
Inclusion Criteria
vagina delivery beyond 34 weeks
primiparity
candidates for episiotomy
Exclusion Criteria
Lack of consent to participate in the study
known coagulopathy
history of previous perineal surgery
uterine atony
retained placenta
delivery with instruments
Cervical rupture at the same time
receiving spontaneous tranexamic acid
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcomes is changes in hemoglobin and hematocrit, the need for blood transfusion, the duration of hospitalization. Timepoint: Hemoglobin and hematocrit check before admission and 12 hours later and also to check complications 1 week after discharge. Method of measurement: Hemoglobin and hematocrit check with blood test (cbc) and check the need for transfusion, discharge time, possible wound opening and thromboembolic events based on history.
- Secondary Outcome Measures
Name Time Method